The epigenetic reader brd4 serves as a novel marker and target in aggressive systemic mastocytosis and mast cell leukemia

Wedeh, G., Cerny-Reiterer, S., Hadzijusufovic, E., Herrmann, H., Blatt, K., Eisenwort, G., Hoermann, G., Sperr, W. R., Muellauer, L., Vakoc, C. R., Bradner, J. E., Horny, H., Zuber, J., Arock, M., Valent, P. (June 2014) The epigenetic reader brd4 serves as a novel marker and target in aggressive systemic mastocytosis and mast cell leukemia. Haematologica, 99. pp. 514-515. ISSN 0390-6078

Item Type: Paper
Additional Information: Meeting Abstract
Subjects: diseases & disorders > cancer
bioinformatics > genomics and proteomics > genetics & nucleic acid processing > protein structure, function, modification > protein types > BET bromodomain coactivator protein > Brd4
diseases & disorders > cancer > cancer types > leukemia
Publication Type > Meeting Abstract
CSHL Authors:
Communities: CSHL labs > Vakoc lab
Depositing User: Matt Covey
Date: June 2014
Date Deposited: 14 Nov 2014 17:49
Last Modified: 06 Feb 2018 21:47
PMCID: PMC4060398
URI: https://repository.cshl.edu/id/eprint/30920

Actions (login required)

Administrator's edit/view item Administrator's edit/view item